Hope S. Rugo, MD, is a researcher for Genentech/Roche, GlaxoSmith-Kline, ImClone, Merck, Novartis, and Sanofi/BiPar, and is on the speakers’ bureau for Bayer, Intellikine, and Genomic Health.

Last modified: June 19, 2012